Serum immunoglobulin A (IgA) was markedly increased in 80% of 50 patients with acute rheumatic fever in Trinidad in contrast to 20% of 63 patients with acute glomerulonephritis, whereas serum IgG was increased in nearly all of both groups. Since total antibody to M-associated protein (MAP) (assessed by complement fixation) is the only antibody as yet consistently found to be of higher titer in patients with acute rheumatic fever than in patients with acute glomerulonephritis in Trinidad, it was measured and the titers were related to serum levels of IgA. The titers of total antibody to MAP were .40 in 58% of the rheumatic fever patients, 43% of the nephritis patients, and 8% of well school-children. However, its presence in rheumatic fever patients did not correlate directly with amounts of serum IgA present (r = 0.0507). Moreover, titers of total antibody to MAP related equally well to enzyme-linked immunosorbent assay indicated amounts of IgG antibody (r = 0.3939) and IgA antibody (r = 0.3054) to MAP in rheumatic fever patients but not in nephritis patients (r = 0.0301 for IgA antibody and 0.6909 for IgG antibody to MAP), whereas they related best to IgM antibody to MAP in the school-children (r = 0.4204). 
For many years we have studied all patients admitted to the General Hospital in San Fernando, Trinidad, with acute glomerulonephritis (AGN) or acute rheumatic fever (ARF) to learn about the pathogenesis of these very different sequelae of group A streptococcal infections. Although different types of streptococci have been associated with the two diseases, we have found little difference in the titers of antibodies to streptolysin 0, hyaluronidase, DNase B, or group A carbohydrate (5, 6). However, investigators at Colindale Laboratories have described higher titers of antibody to streptococcal Massociated protein (MAP) in patients with ARF than in patients with AGN in Trinidad as well as elsewhere (13, 14) . In the present study, we found that serum immunoglobulin A (IgA) also was more increased in patients with ARF than in patients with AGN whereas serum IgG was increased in both groups of patients. Therefore, we looked for correlation between serum IgA levels and antibodies to MAP. We also tried to identify the antibodies to MAP as IgA antibodies by applying the enzyme-linked immunosorbent assay (ELISA) technique to their assay.
MATERIALS AND METHODS
Clinical material. AGN was diagnosed when patients had sudden appearance of hematuria or edema or both, proteinuria, and decreased serum BIc globulin plus evidence of recent streptococcal infection. ARF was diagnosed when patients had at least two major Jones criteria (2) or one major and two minor Jones criteria, plus evidence of recent streptococcal infection. Twenty AGN patients with scabies, 33 AGN patients with skin infections but no scabies, and 10 AGN patients without either were selected for study along with 50 patients with ARF, none of whom had skin infections. Acute-phase sera were obtained from all patients within 1 to 3 days of admission to the hospital, and follow-up sera were obtained from 24 of the AGN patients 3 to 12 weeks after admission. Sera also were obtained from 50 well school-children 5 to 8 years old for control values. All sera were frozen and (Fig. 1) .
In contrast to IgA, IgG values were increased in both AGN (mean, 2,080 mg/dl) and ARF (mean, 2,345 mg/dl) patients (Fig. 1) (Fig. 3) . The (Fig. 4) . Only 9 of the 24 sera studied differed more than 50 mg/dl in either globulin from the acute-phase serum.
Anti TA-MAP by complement fixation assay. TA-MAP were increased (titers. , 40) in more ARF patients (58% of 40 studied) than AGN patients (43% of 39 studied) (P < 0.05) and in more AGN patients than normal school-children (8% of 27 studied) (P < 0.002). Mean titers also were higher in ARF patients (42.8) than in AGN patients (31.9) (P < 0.05) and in AGN patients than in school-children (23.1) (P < 0.002). Cumulative titers of these antibodies in ARF patients, AGN patients, and school-children are shown in Fig. 5 (a fourfold dilution of 1/1,600) had approximately one-half the readings at 410 nm of the 1/1,600 dilutions. Fortunately, we were able to compare readings at 410 nm of the same dilutions of sera from patients with ARF and AGN and normal school-children since these dilutions were optimal for each class of antibody in all study groups.
Respective amounts of IgG, IgA, and IgM antibodies bound by the MAP antigen from the sera of ARF patients were slightly higher than those bound from the sera of AGN patients which, in turn, were higher than those bound from the sera of school children (Fig. 6) . Thus, these observations agree with those of the TA-MAP assays by complement fixation. More IgM than IgA and more IgA than IgG were bound at these dilutions from all of the sera studied, but these figures must be corrected for the dilutions of sera used for assay of respective classes of antibody, as discussed above.
Attempts were made to correlate the TA-MAP titers with IgG, IgA, or IgM antibodies by plotting them against each other (Fig. 7) . Amounts of IgG antibody were greatest in the six ARF or AGN patients' sera with TA-MAP titers of 160, whereas this correlation was absent in the school-children: those with the highest TA-MAP titers (40 and 80) had increased IgM antibody rather than IgG antibody. IgA antibody titers increased with increase in TA-MAP titers in ARF patients (P < 0.05; r = 0.3954) but so did the IgG antibody titers (P < 0.05; r = 0.3929).
IgA antibody titers showed no correlation with TA-MAP titers in AGN patients (P > 0.1; r = 0.0301), whereas IgG antibodies did (P < 0.001); r = 0.6909). MAP titers by complement fixation (Fig. 8) 
